Large Molecule Bioanalytical Technologies Market Size, Share & Trends Analysis Report By Product, By Technology (Chromatography, Electrophoresis), By Application, By Region, And Segment Forecasts, 2021 - 2028
This report can be delivered to the clients within 72 Business Hours
Large Molecule Bioanalytical Technologies Market Growth & Trends
The global large molecule bioanalytical technologies market size is expected to reach USD 13.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 13.5% from 2021 to 2028. The demand for bioanalytical testing services has significantly increased over the past few years, thereby positively impacting the growth of the market.
This is primarily due to the growing R&D activities in the biopharmaceutical industry, leading to notable investments in the space. Also, the ongoing pandemic of COVID-19 has resulted in the expansion of manufacturing and R&D capabilities of key stakeholders leading to increased demand for bioanalytical testing services. The use of advanced technologies in vaccine and cell gene therapy development has led to significant growth of this space.
Advancements in instrumentation have created lucrative opportunities for contract manufacturers. Over the past several years, biopharmaceutical manufacturers are outsourcing at least some part of their biomanufacturing activities. Analytical testing is one of the most outsourced activities as it requires highly specialized personnel and equipment to conduct assays. These factors are anticipated to play a vital role in shaping market growth.
Large Molecule Bioanalytical Technologies Market Report Highlights
Large Molecule Bioanalytical Technologies Market Growth & Trends
The global large molecule bioanalytical technologies market size is expected to reach USD 13.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 13.5% from 2021 to 2028. The demand for bioanalytical testing services has significantly increased over the past few years, thereby positively impacting the growth of the market.
This is primarily due to the growing R&D activities in the biopharmaceutical industry, leading to notable investments in the space. Also, the ongoing pandemic of COVID-19 has resulted in the expansion of manufacturing and R&D capabilities of key stakeholders leading to increased demand for bioanalytical testing services. The use of advanced technologies in vaccine and cell gene therapy development has led to significant growth of this space.
Advancements in instrumentation have created lucrative opportunities for contract manufacturers. Over the past several years, biopharmaceutical manufacturers are outsourcing at least some part of their biomanufacturing activities. Analytical testing is one of the most outsourced activities as it requires highly specialized personnel and equipment to conduct assays. These factors are anticipated to play a vital role in shaping market growth.
Large Molecule Bioanalytical Technologies Market Report Highlights
- The product segment accounted for the largest revenue share in 2020
- Biopharmaceutical products require various instruments for characterization, identification, purity, and potency testing
- Availability of a wide range of products for the aforementioned assay applications is the key factor contributing to segment growth
- Mass spectrometry captured the maximum revenue share in 2020 due to the diversification of products as well as their frequent usage
- This technology has been conventionally used in the development of protein pharmaceuticals, for instance, in the analysis of confirmations of amino acids in proteins
- Furthermore, quantitative PCR (qPCR) is widely adopted in the detection of viral contaminants during the manufacture of biopharmaceuticals
- Thus, with the growing demand for viral vectors, this technology is anticipated to witness the fastest growth over the forecast period
- Moreover, the presence of a wide array of products in spectrometry is one of the key industry factors driving investment in the segment
- Biologics accounted for the major revenue share in 2020 owing to the ever-expanding R&D activity programs in the segment
- Besides, the presence of a stringent regulatory framework for advanced therapies has increased the demand for bioanalytical testing services
- The COVID-19 pandemic has accelerated the development of genetic vaccines
- This increases the utility of analytical tools for assessing the safety and stability of large molecules, thereby driving the segment
- North America dominated the market in 2020 owing to the presence of strong research as well as a commercial base for biopharmaceutical manufacturing
- Moreover, the U.S. is the largest biopharmaceutical market that has positively influenced the adoption and usage of large molecule bioanalytical technologies in the region
- In the Asia Pacific, the market is estimated to register the fastest CAGR with emerging markets such as China and Japan at the forefront
- Collaborations between domestic and global players for expansion of biomanufacturing capabilities are supplementing the growth of the market in the region
- Key companies are focusing on new product launches to sustain their position in the market
CHAPTER 1 EXECUTIVE SUMMARY
1.1 Market Summary
CHAPTER 2 RESEARCH METHODOLOGY
2.1 Information Procurement
2.2 Information or Data Analysis
2.2.1 Market study
2.2.1.1 KOL Opinions
2.2.1.1.1 KOL Opinions: Downside Scenario
2.2.1.1.2 KOL Opininos: Future market landscape
2.2.1.1.3 KOL Opinions: Technological development
2.2.1.2 Technology Study
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlooK
3.1.2 Ancillary market outlooK
3.1.2.1 Protein Stability Analysis Market: Market Outlook
3.2 Market Segmentation and Scope
3.3 Market Dynamics
3.3.1 Market driver Analysis
3.3.1.1 Technological advancements in life science tools and analytical instruments
3.3.1.2 Rising collaboration between operating stakeholders
3.3.1.3 Rising advancements, automation, and expansion in laboratory facilities
3.3.2 Market Restraint Analysis
3.3.2.1 Timeline, speed & cost-related challenges
3.3.2.2 Complicated bioanalytical assays due to complex nature of large molecules
3.3.2.3 Challenges associated with sample preparation
3.3.3 Market Opportunity Analysis
3.3.3.1 Vaccine development against SARS-CoV-2 infection
3.3.3.2 Commercial success of biopharmaceuticals and consequent increase in demand for biopharmaceuticals
3.3.3.2.1 Notable growth of biologics & biosimilars
3.3.4 Market threat Analysis
3.3.4.1 Dominance of small molecule
3.4 COVID-19 Impact analysis
3.4.1 Short-term impact
3.4.2 Long-term impact
3.4.3 Challenge Analysis
3.4.4 Opportunity Analysis
3.4.4.1 Key developments & activities
3.5 Penetration & Growth Prospect Mapping for Therapeutic Applications, 2020
3.6 Porter’s Analysis
3.7 COVID-19 Impact Analysis
CHAPTER 4 PRODUCT & SERVICE BUSINESS ANALYSIS
4.1 Market: Product & Service Movement Analysis
4.2 Products
4.2.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
4.2.2 Consumables & Accessories
4.2.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
4.2.3 Instruments
4.2.3.1 Market estimates and forecast, 2017 - 2028 (USD Million)
4.2.4 Reagents & Kits
4.2.4.1 Market estimates and forecast, 2017 - 2028 (USD Million)
4.3 Services
4.3.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
CHAPTER 5 TECHNOLOGY BUSINESS ANALYSIS
5.1 Market: Technology Movement Analysis
5.2 Electrophoresis
5.2.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.3 Chromatography
5.3.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.4 Mass Spectrometry
5.4.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.5 Western Blot
5.5.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.6 ddPCR, qPCR, RT-PCR
5.6.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.7 ELISA
5.7.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.8 Flow Cytometry
5.8.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9 Spectrometer
5.9.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9.2 UV/Vis
5.9.2.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9.3 CD
5.9.3.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9.4 Raman
5.9.4.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9.5 Laser-induced breakdown spectroscopy
5.9.5.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9.6 Other Spectroscopy techniques
5.9.6.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.10 Analytical ultracentrifugation
5.10.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.11 Light scattering (MALS, DLS) & static light scattering
5.11.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.12 DNA Sequencing
5.12.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.13 Other Technologies
5.13.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
CHAPTER 6 THERAPEUTIC APPLICATION BUSINESS ANALYSIS
6.1 Market: Therapeutic Application Movement Analysis
6.2 Biologics
6.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
6.2.2 By Type
6.2.2.1 mAbs
6.2.2.1.1 Market estimates and forecast, 2017 - 2028 (USD Million)
6.2.2.2 Vaccines
6.2.2.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
6.2.2.3 Recombinant proteins
6.2.2.3.1 Market estimates and forecast, 2017 - 2028 (USD Million)
6.2.3 By Technology
6.2.3.1 Spectrometer
6.2.3.1.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.2 Western Blot
6.2.3.2.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.3 Isoelectric Focusing
6.2.3.3.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.4 Capillary Electrophoresis
6.2.3.4.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.5 Peptide mapping and sequencing by LC-MS/MS
6.2.3.5.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.6 Peptide fingerprinting by Chromatography and Mass Spectrometry (MS)
6.2.3.6.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.7 ddPCR, qPCR, RT-PCR
6.2.3.7.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.8 Other Technologies
6.2.3.8.1 Market analysis, 2017 - 2028 (USD Million)
6.3 Cell & Nucleic Acid Therapy
6.3.1 Market estimates and forecast for cell therapy, 2017 - 2028 (USD Million)
6.3.2 SDS-PAGE or Capillary Electrophoresis
6.3.2.1 Market analysis, 2017 - 2028 (USD Million)
6.3.3 Chromatography
6.3.3.1 Market analysis, 2017 - 2028 (USD Million)
6.3.4 Mass Spectrometry/LC-MS
6.3.4.1 Market analysis, 2017 - 2028 (USD Million)
6.3.5 UV/Vis Spectrometry
6.3.5.1 Market analysis, 2017 - 2028 (USD Million)
6.3.6 ddPCR, qPCR, RT-PCR
6.3.6.1 Market analysis, 2017 - 2028 (USD Million)
6.3.7 ELISA Assays
6.3.7.1 Market analysis, 2017 - 2028 (USD Million)
6.3.8 Fluroscent Assays
6.3.8.1 Market analysis, 2017 - 2028 (USD Million)
6.3.9 Luminescent Assays
6.3.9.1 Market analysis, 2017 - 2028 (USD Million)
6.3.10 Western Blot
6.3.10.1 Market analysis, 2017 - 2028 (USD Million)
6.3.11 Flow cytometry
6.3.11.1 Market analysis, 2017 - 2028 (USD Million)
6.3.12 Other technologies
6.3.12.1 Market analysis, 2017 - 2028 (USD Million)
6.4 Viral Vector
6.4.1 Market estimates and forecast for viral vector, 2017 - 2028 (USD Million)
6.4.2 Sanger
6.4.2.1 Market analysis, 2017 - 2028 (USD Million)
6.4.3 ddPCR, qPCR, RT-PCR
6.4.3.1 Market analysis, 2017 - 2028 (USD Million)
6.4.4 ELISA
6.4.4.1 Market analysis, 2017 - 2028 (USD Million)
6.4.5 Electrophoresis
6.4.5.1 Market analysis, 2017 - 2028 (USD Million)
6.4.6 NGS
6.4.6.1 Market analysis, 2017 - 2028 (USD Million)
6.4.7 Mass Spectrometry
6.4.7.1 Market analysis, 2017 - 2028 (USD Million)
6.4.8 Chromatography
6.4.8.1 Market analysis, 2017 - 2028 (USD Million)
6.4.9 Dynamic & Static light scattering
6.4.9.1 Market analysis, 2017 - 2028 (USD Million)
6.4.10 Other Technologies
6.4.10.1 Market analysis, 2017 - 2028 (USD Million)
6.5 Gene Therapy
6.5.1 Market Estimates And Forecast For Gene Therapy, 2017 - 2028 (USD Million)
6.5.2 SDS-PAGE or Capillary Electrophoresis
6.5.2.1 Market analysis, 2017 - 2028 (USD Million)
6.5.3 Chromatography
6.5.3.1 Market analysis, 2017 - 2028 (USD Million)
6.5.4 Mass Spectrometry/LC-MS
6.5.4.1 Market analysis, 2017 - 2028 (USD Million)
6.5.5 UV/Vis Spectrometry
6.5.5.1 Market analysis, 2017 - 2028 (USD Million)
6.5.6 ddPCR, qPCR, RT-PCR
6.5.6.1 Market analysis, 2017 - 2028 (USD Million)
6.5.7 ELISA Assays
6.5.7.1 Market analysis, 2017 - 2028 (USD Million)
6.5.8 Fluroscent Assays
6.5.8.1 Market analysis, 2017 - 2028 (USD Million)
6.5.9 Luminescent Assays
6.5.9.1 Market analysis, 2017 - 2028 (USD Million)
6.5.10 Western Blot
6.5.10.1 Market analysis, 2017 - 2028 (USD Million)
6.5.11 Flow cytometry
6.5.11.1 Market analysis, 2017 - 2028 (USD Million)
6.5.12 Other technologies
6.5.12.1 Market analysis, 2017 - 2028 (USD Million)
6.6 Nanoparticles and Polymers
6.6.1 Market Estimates And Forecast For Nanoparticles And Polymers, 2017 - 2028 (USD Million)
6.6.2 Dynamic & static light scattering
6.6.2.1 Market analysis, 2017 - 2028 (USD Million)
6.6.3 Lasser Diffraction
6.6.3.1 Market analysis, 2017 - 2028 (USD Million)
6.6.4 Fluroscence Spectrometry
6.6.4.1 Market analysis, 2017 - 2028 (USD Million)
6.6.5 Other Technologies
6.6.5.1 Market analysis, 2017 - 2028 (USD Million)
CHAPTER 7 REGIONAL BUSINESS ANALYSIS
7.1 Market: Regional Movement Analysis, 2020 & 2028
7.2 North America
7.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
7.2.2 Market estimates and forecast, by product & service, 2017 - 2028 (USD Milliion)
7.2.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.2.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.2.2 U.S.
7.2.2.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.2.2.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.2.2.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.2.3 Canada
7.2.3.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.2.3.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.2.3.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.3 Europe
7.3.1 Market estimates and forecast, 2017 - 2028 (USD Million)
7.3.2 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.3.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.3.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.3.5 Germany
7.3.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.3.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.3.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.6 U.K.
7.6.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.6.2 Market estimates land forecast, by technology, 2017 - 2028 (USD Million)
7.6.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.7 France
7.6.7.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.7.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.7.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.8 Italy
7.6.8.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.8.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.8.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.9 Spain
7.6.9.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.9.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.9.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Market estimates and forecast, 2017 - 2028 (USD Million)
7.4.2 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.4.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.4.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.4.5 Japan
7.4.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.4.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.4.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.4.6 China
7.4.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.4.6.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.4.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.4.7 India
7.4.7.1 Market estimates and forecast, by product &service, 2017 - 2028 (USD Million)
7.4.7.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.4.7.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.4.8 South Korea
7.4.8.1 Market estimates and forecast, by product &service, 2017 - 2028 (USD Million)
7.4.8.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.4.8.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.5 Latin America
7.5.1 Market estimates and forecast, 2017 - 2028 (USD Million)
7.5.2 Market estimates and forecast, by product & services, 2017 - 2028 (USD Million)
7.5.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.5.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.5.5 Brazil
7.5.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.5.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.5.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.5.6 Mexico
7.5.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.5.6.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.5.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6 Middle East and Africa (MEA)
7.6.1 Market estimates and forecast, 2017 - 2028 (USD Million)
7.6.2 Market estimates and forecast, by product & services, 2017 - 2028 (USD Million)
7.6.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.5 South Africa
7.6.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.6.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
CHAPTER 8 COMPETITVE ANALYSIS
8.1 Large Molecule Bioanalytical Technologies Market: Vendor Landscape
8.2 Strategy Framework
8.3 Company Categorization
8.4 Company Profiles - Large Molecule Stability Market
8.4.1 Intertek Group plc.
8.4.1.1 Company overview
8.4.1.2 Financial Performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 SOLVIAS AG
8.4.2.1 Company overview
8.4.2.2 Product benchmarking
8.4.2.3 Strategic initiatives
8.4.3 Bio-Techne Corporation
8.4.3.1 Company overview
8.4.3.2 ProteinSimple
8.4.3.3 Financial Performance
8.4.3.4 Product benchmarking
8.4.3.5 Strategic initiatives
8.4.4 Wyatt Technology Corporation
8.4.4.1 Company overview
8.4.4.2 Product benchmarking
8.4.4.3 Strategic initiatives
8.4.5 Precision NanoSystems
8.4.5.1 Company overview
8.4.5.2 Product benchmarking
8.4.6 Verder
8.4.6.1 Company overview
8.4.6.2 Product benchmarking
8.4.6.3 Strategic initiatives
8.4.7 Halo Labs
8.4.7.1 Company overview
8.4.7.2 Product benchmarking
8.4.7.3 Strategic initiatives
8.4.8 Charles River Laboratories International, Inc.
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 Avomeen
8.4.9.1 Company overview
8.4.9.2 Product benchmarking
8.4.9.3 strategic initiatives
8.4.10 Merck KGaA
8.4.10.1 Company overview
8.4.10.2 Financial Performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives
8.4.11 Cergentis B.V.
8.4.11.1 Company overview
8.4.11.2 Product benchmarking
8.4.11.3 strategic initiatives
8.4.12 Laboratory Corporation of America Holdings
8.4.12.1 Company overview
8.4.12.2 Covance
8.4.12.3 Financial Performance
8.4.12.4 Product benchmarking
8.4.12.5 Strategic initiatives
8.4.13 DH Tech. Dev. Pte. Ltd. (SCIEX)
8.4.13.1 Company overview
8.4.13.2 Product benchmarking
8.4.13.3 Strategic initiatives
8.4.14 F. Hoffmann-La Roche Ltd
8.4.14.1 Company overview
8.4.14.2 Financial Performance
8.4.14.3 Product benchmarking
8.4.14.4 Strategic initiatives
8.4.15 Bio-Rad Laboratories, Inc.
8.4.15.1 Company overview
8.4.15.2 Financial Performance
8.4.15.3 Product benchmarking
8.4.15.4 Strategic initiatives
1.1 Market Summary
CHAPTER 2 RESEARCH METHODOLOGY
2.1 Information Procurement
2.2 Information or Data Analysis
2.2.1 Market study
2.2.1.1 KOL Opinions
2.2.1.1.1 KOL Opinions: Downside Scenario
2.2.1.1.2 KOL Opininos: Future market landscape
2.2.1.1.3 KOL Opinions: Technological development
2.2.1.2 Technology Study
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlooK
3.1.2 Ancillary market outlooK
3.1.2.1 Protein Stability Analysis Market: Market Outlook
3.2 Market Segmentation and Scope
3.3 Market Dynamics
3.3.1 Market driver Analysis
3.3.1.1 Technological advancements in life science tools and analytical instruments
3.3.1.2 Rising collaboration between operating stakeholders
3.3.1.3 Rising advancements, automation, and expansion in laboratory facilities
3.3.2 Market Restraint Analysis
3.3.2.1 Timeline, speed & cost-related challenges
3.3.2.2 Complicated bioanalytical assays due to complex nature of large molecules
3.3.2.3 Challenges associated with sample preparation
3.3.3 Market Opportunity Analysis
3.3.3.1 Vaccine development against SARS-CoV-2 infection
3.3.3.2 Commercial success of biopharmaceuticals and consequent increase in demand for biopharmaceuticals
3.3.3.2.1 Notable growth of biologics & biosimilars
3.3.4 Market threat Analysis
3.3.4.1 Dominance of small molecule
3.4 COVID-19 Impact analysis
3.4.1 Short-term impact
3.4.2 Long-term impact
3.4.3 Challenge Analysis
3.4.4 Opportunity Analysis
3.4.4.1 Key developments & activities
3.5 Penetration & Growth Prospect Mapping for Therapeutic Applications, 2020
3.6 Porter’s Analysis
3.7 COVID-19 Impact Analysis
CHAPTER 4 PRODUCT & SERVICE BUSINESS ANALYSIS
4.1 Market: Product & Service Movement Analysis
4.2 Products
4.2.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
4.2.2 Consumables & Accessories
4.2.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
4.2.3 Instruments
4.2.3.1 Market estimates and forecast, 2017 - 2028 (USD Million)
4.2.4 Reagents & Kits
4.2.4.1 Market estimates and forecast, 2017 - 2028 (USD Million)
4.3 Services
4.3.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
CHAPTER 5 TECHNOLOGY BUSINESS ANALYSIS
5.1 Market: Technology Movement Analysis
5.2 Electrophoresis
5.2.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.3 Chromatography
5.3.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.4 Mass Spectrometry
5.4.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.5 Western Blot
5.5.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.6 ddPCR, qPCR, RT-PCR
5.6.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.7 ELISA
5.7.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.8 Flow Cytometry
5.8.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9 Spectrometer
5.9.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9.2 UV/Vis
5.9.2.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9.3 CD
5.9.3.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9.4 Raman
5.9.4.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9.5 Laser-induced breakdown spectroscopy
5.9.5.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.9.6 Other Spectroscopy techniques
5.9.6.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.10 Analytical ultracentrifugation
5.10.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.11 Light scattering (MALS, DLS) & static light scattering
5.11.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.12 DNA Sequencing
5.12.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
5.13 Other Technologies
5.13.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
CHAPTER 6 THERAPEUTIC APPLICATION BUSINESS ANALYSIS
6.1 Market: Therapeutic Application Movement Analysis
6.2 Biologics
6.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
6.2.2 By Type
6.2.2.1 mAbs
6.2.2.1.1 Market estimates and forecast, 2017 - 2028 (USD Million)
6.2.2.2 Vaccines
6.2.2.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
6.2.2.3 Recombinant proteins
6.2.2.3.1 Market estimates and forecast, 2017 - 2028 (USD Million)
6.2.3 By Technology
6.2.3.1 Spectrometer
6.2.3.1.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.2 Western Blot
6.2.3.2.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.3 Isoelectric Focusing
6.2.3.3.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.4 Capillary Electrophoresis
6.2.3.4.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.5 Peptide mapping and sequencing by LC-MS/MS
6.2.3.5.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.6 Peptide fingerprinting by Chromatography and Mass Spectrometry (MS)
6.2.3.6.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.7 ddPCR, qPCR, RT-PCR
6.2.3.7.1 Market analysis, 2017 - 2028 (USD Million)
6.2.3.8 Other Technologies
6.2.3.8.1 Market analysis, 2017 - 2028 (USD Million)
6.3 Cell & Nucleic Acid Therapy
6.3.1 Market estimates and forecast for cell therapy, 2017 - 2028 (USD Million)
6.3.2 SDS-PAGE or Capillary Electrophoresis
6.3.2.1 Market analysis, 2017 - 2028 (USD Million)
6.3.3 Chromatography
6.3.3.1 Market analysis, 2017 - 2028 (USD Million)
6.3.4 Mass Spectrometry/LC-MS
6.3.4.1 Market analysis, 2017 - 2028 (USD Million)
6.3.5 UV/Vis Spectrometry
6.3.5.1 Market analysis, 2017 - 2028 (USD Million)
6.3.6 ddPCR, qPCR, RT-PCR
6.3.6.1 Market analysis, 2017 - 2028 (USD Million)
6.3.7 ELISA Assays
6.3.7.1 Market analysis, 2017 - 2028 (USD Million)
6.3.8 Fluroscent Assays
6.3.8.1 Market analysis, 2017 - 2028 (USD Million)
6.3.9 Luminescent Assays
6.3.9.1 Market analysis, 2017 - 2028 (USD Million)
6.3.10 Western Blot
6.3.10.1 Market analysis, 2017 - 2028 (USD Million)
6.3.11 Flow cytometry
6.3.11.1 Market analysis, 2017 - 2028 (USD Million)
6.3.12 Other technologies
6.3.12.1 Market analysis, 2017 - 2028 (USD Million)
6.4 Viral Vector
6.4.1 Market estimates and forecast for viral vector, 2017 - 2028 (USD Million)
6.4.2 Sanger
6.4.2.1 Market analysis, 2017 - 2028 (USD Million)
6.4.3 ddPCR, qPCR, RT-PCR
6.4.3.1 Market analysis, 2017 - 2028 (USD Million)
6.4.4 ELISA
6.4.4.1 Market analysis, 2017 - 2028 (USD Million)
6.4.5 Electrophoresis
6.4.5.1 Market analysis, 2017 - 2028 (USD Million)
6.4.6 NGS
6.4.6.1 Market analysis, 2017 - 2028 (USD Million)
6.4.7 Mass Spectrometry
6.4.7.1 Market analysis, 2017 - 2028 (USD Million)
6.4.8 Chromatography
6.4.8.1 Market analysis, 2017 - 2028 (USD Million)
6.4.9 Dynamic & Static light scattering
6.4.9.1 Market analysis, 2017 - 2028 (USD Million)
6.4.10 Other Technologies
6.4.10.1 Market analysis, 2017 - 2028 (USD Million)
6.5 Gene Therapy
6.5.1 Market Estimates And Forecast For Gene Therapy, 2017 - 2028 (USD Million)
6.5.2 SDS-PAGE or Capillary Electrophoresis
6.5.2.1 Market analysis, 2017 - 2028 (USD Million)
6.5.3 Chromatography
6.5.3.1 Market analysis, 2017 - 2028 (USD Million)
6.5.4 Mass Spectrometry/LC-MS
6.5.4.1 Market analysis, 2017 - 2028 (USD Million)
6.5.5 UV/Vis Spectrometry
6.5.5.1 Market analysis, 2017 - 2028 (USD Million)
6.5.6 ddPCR, qPCR, RT-PCR
6.5.6.1 Market analysis, 2017 - 2028 (USD Million)
6.5.7 ELISA Assays
6.5.7.1 Market analysis, 2017 - 2028 (USD Million)
6.5.8 Fluroscent Assays
6.5.8.1 Market analysis, 2017 - 2028 (USD Million)
6.5.9 Luminescent Assays
6.5.9.1 Market analysis, 2017 - 2028 (USD Million)
6.5.10 Western Blot
6.5.10.1 Market analysis, 2017 - 2028 (USD Million)
6.5.11 Flow cytometry
6.5.11.1 Market analysis, 2017 - 2028 (USD Million)
6.5.12 Other technologies
6.5.12.1 Market analysis, 2017 - 2028 (USD Million)
6.6 Nanoparticles and Polymers
6.6.1 Market Estimates And Forecast For Nanoparticles And Polymers, 2017 - 2028 (USD Million)
6.6.2 Dynamic & static light scattering
6.6.2.1 Market analysis, 2017 - 2028 (USD Million)
6.6.3 Lasser Diffraction
6.6.3.1 Market analysis, 2017 - 2028 (USD Million)
6.6.4 Fluroscence Spectrometry
6.6.4.1 Market analysis, 2017 - 2028 (USD Million)
6.6.5 Other Technologies
6.6.5.1 Market analysis, 2017 - 2028 (USD Million)
CHAPTER 7 REGIONAL BUSINESS ANALYSIS
7.1 Market: Regional Movement Analysis, 2020 & 2028
7.2 North America
7.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
7.2.2 Market estimates and forecast, by product & service, 2017 - 2028 (USD Milliion)
7.2.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.2.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.2.2 U.S.
7.2.2.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.2.2.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.2.2.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.2.3 Canada
7.2.3.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.2.3.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.2.3.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.3 Europe
7.3.1 Market estimates and forecast, 2017 - 2028 (USD Million)
7.3.2 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.3.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.3.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.3.5 Germany
7.3.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.3.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.3.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.6 U.K.
7.6.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.6.2 Market estimates land forecast, by technology, 2017 - 2028 (USD Million)
7.6.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.7 France
7.6.7.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.7.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.7.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.8 Italy
7.6.8.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.8.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.8.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.9 Spain
7.6.9.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.9.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.9.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Market estimates and forecast, 2017 - 2028 (USD Million)
7.4.2 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.4.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.4.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.4.5 Japan
7.4.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.4.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.4.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.4.6 China
7.4.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.4.6.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.4.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.4.7 India
7.4.7.1 Market estimates and forecast, by product &service, 2017 - 2028 (USD Million)
7.4.7.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.4.7.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.4.8 South Korea
7.4.8.1 Market estimates and forecast, by product &service, 2017 - 2028 (USD Million)
7.4.8.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.4.8.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.5 Latin America
7.5.1 Market estimates and forecast, 2017 - 2028 (USD Million)
7.5.2 Market estimates and forecast, by product & services, 2017 - 2028 (USD Million)
7.5.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.5.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.5.5 Brazil
7.5.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.5.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.5.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.5.6 Mexico
7.5.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.5.6.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.5.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6 Middle East and Africa (MEA)
7.6.1 Market estimates and forecast, 2017 - 2028 (USD Million)
7.6.2 Market estimates and forecast, by product & services, 2017 - 2028 (USD Million)
7.6.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.5 South Africa
7.6.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
7.6.6.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
7.6.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
CHAPTER 8 COMPETITVE ANALYSIS
8.1 Large Molecule Bioanalytical Technologies Market: Vendor Landscape
8.2 Strategy Framework
8.3 Company Categorization
8.4 Company Profiles - Large Molecule Stability Market
8.4.1 Intertek Group plc.
8.4.1.1 Company overview
8.4.1.2 Financial Performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 SOLVIAS AG
8.4.2.1 Company overview
8.4.2.2 Product benchmarking
8.4.2.3 Strategic initiatives
8.4.3 Bio-Techne Corporation
8.4.3.1 Company overview
8.4.3.2 ProteinSimple
8.4.3.3 Financial Performance
8.4.3.4 Product benchmarking
8.4.3.5 Strategic initiatives
8.4.4 Wyatt Technology Corporation
8.4.4.1 Company overview
8.4.4.2 Product benchmarking
8.4.4.3 Strategic initiatives
8.4.5 Precision NanoSystems
8.4.5.1 Company overview
8.4.5.2 Product benchmarking
8.4.6 Verder
8.4.6.1 Company overview
8.4.6.2 Product benchmarking
8.4.6.3 Strategic initiatives
8.4.7 Halo Labs
8.4.7.1 Company overview
8.4.7.2 Product benchmarking
8.4.7.3 Strategic initiatives
8.4.8 Charles River Laboratories International, Inc.
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 Avomeen
8.4.9.1 Company overview
8.4.9.2 Product benchmarking
8.4.9.3 strategic initiatives
8.4.10 Merck KGaA
8.4.10.1 Company overview
8.4.10.2 Financial Performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives
8.4.11 Cergentis B.V.
8.4.11.1 Company overview
8.4.11.2 Product benchmarking
8.4.11.3 strategic initiatives
8.4.12 Laboratory Corporation of America Holdings
8.4.12.1 Company overview
8.4.12.2 Covance
8.4.12.3 Financial Performance
8.4.12.4 Product benchmarking
8.4.12.5 Strategic initiatives
8.4.13 DH Tech. Dev. Pte. Ltd. (SCIEX)
8.4.13.1 Company overview
8.4.13.2 Product benchmarking
8.4.13.3 Strategic initiatives
8.4.14 F. Hoffmann-La Roche Ltd
8.4.14.1 Company overview
8.4.14.2 Financial Performance
8.4.14.3 Product benchmarking
8.4.14.4 Strategic initiatives
8.4.15 Bio-Rad Laboratories, Inc.
8.4.15.1 Company overview
8.4.15.2 Financial Performance
8.4.15.3 Product benchmarking
8.4.15.4 Strategic initiatives
LIST OF TABLES
Table 1 Company mapping for Large molecule bioanalytical technologies analysis, by technology
Table 2 Company mapping for Large molecule bioanalytical technologies analysis, by molecule type
Table 3 List of key technology supplier
Table 4 Some commercially available portable and handheld instruments
Table 5 Pandemic-related changes or trends in long term
Table 6 Testing types and methods
Table 7 Overview of analytical methods used in viral vector manufacturing
Table 8 North America large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 9 North America large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 10 North America large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 11 North America spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 12 North America large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 13 North America biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 14 North America biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 15 North America viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 16 North America cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 17 North America gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 18 North America nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 19 U.S. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 20 U.S. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 21 U.S. large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 22 U.S. spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 23 U.S. large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 24 U.S. biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 25 U.S. biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 26 U.S. viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 27 U.S. cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 28 U.S. gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 29 U.S. nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 30 Canada large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 31 Canada large molecule bioanalytical technologies product & service market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 32 Canada large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 33 Canada spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 34 Canada large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 35 Canada biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 36 Canada biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 37 Canada viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 38 Canada cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 39 Canada gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 40 Canada nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 41 Europe. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 42 Europe. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 43 Europe large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 44 Europe spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 45 Europe large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 46 Europe biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 47 Europe biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 48 Europe viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 49 Europe cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 50 Europe gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 51 Europe nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 52 Germany. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 53 Germany. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 54 Germany large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 55 Germany spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 56 Germany large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 57 Germany biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 58 Germany biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 59 Germany viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 60 Germany cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 61 Germany gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 62 Germany nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 63 U.K. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 64 U.K. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 65 U.K. large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 66 U.K. spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 67 U.K. large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 68 U.K. biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 69 U.K. biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 70 U.K. viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 71 U.K. cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 72 U.K. gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 73 U.K. nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 74 France. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 75 France large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 76 France large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 77 France spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 78 France large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 79 France biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 80 France biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 81 France viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 82 France cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 83 France gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 84 France nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 85 Italy large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 86 Italy large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 87 Italy large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 88 Italy spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 89 Italy large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 90 Italy biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 91 Italy biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 92 Italy viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 93 Italy cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 94 Italy gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 95 Italy nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 96 Spain. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 97 Spain. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 98 Spain large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 99 Spain spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 100 Spain large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 101 Spain biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 102 Spain biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 103 Spain viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 104 Spain cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 105 Spain gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 106 Spain nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 107 Asia Pacific. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 108 Asia Pacific. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 109 Asia Pacific large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 110 Asia Pacific spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 111 Asia Pacific large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 112 Asia Pacific biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 113 Asia Pcific biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 114 Asia Pacific viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 115 Asia Pacific cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 116 Asia Pacific gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 117 Asia Pacific nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 118 Japan large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 119 Japan large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 120 Japan large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 121 Japan spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 122 Japan large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 123 Japan biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 124 Japan biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 125 Japan viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 126 Japan cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 127 Japan gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 128 Japan nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 129 China large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 130 China large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 131 China large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 132 China spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 133 China large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 134 China biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 135 China biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 136 China viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 137 China cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 138 China gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 139 China nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 140 India large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 141 India large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 142 India large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 143 India spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 144 India large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 145 India biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 146 India biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 147 India viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 148 India cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 149 India gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 150 India nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 151 South Korea large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 152 South Korea large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 153 South Korea large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 154 South Korea spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 155 South Korea large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 156 South Korea biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 157 South Korea biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 158 South Korea viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 159 South Korea cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 160 South Korea gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 161 South Korea nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 162 Latin America large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 163 Latin America. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 164 Latin America large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 165 Latin America spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 166 Latin America large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 167 Latin America biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 168 Latin America biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 169 Latin America viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 170 Latin America cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 171 Latin America gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 172 Latin America nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 173 Brazil large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 174 Brazil. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 175 Brazil large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 176 Brazil spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 177 Brazil large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 178 Brazil biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 179 Brazil biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 180 Brazil viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 181 Brazil cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 182 Brazil gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 183 Brazil nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 184 Mexico large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 185 Mexico. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 186 Mexico large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 187 Mexico spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 188 Mexico large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 189 Mexico biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 190 Mexico biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 191 Mexico viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 192 Mexico cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 193 Mexico gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 194 Mexico nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 195 MEA large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 196 MEA large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 197 MEA large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 198 MEA spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 199 MEA large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 200 MEA biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 201 MEA biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 202 MEA viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 203 MEA cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 204 MEA gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 205 MEA nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 206 South Africa large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 207 South Africa large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 208 South Africa large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 209 South Africa spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 210 South Africa large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 211 South Africa biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 212 South Africa biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 213 South Africa viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 214 South Africa cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 215 South Africa gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 216 South Africa nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 217 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 218 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 219 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 220 Saudi Arabia spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 221 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 222 Saudi Arabia biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 223 Saudi Arabia biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 224 Saudi Arabia viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 225 Saudi Arabia cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 226 Saudi Arabia gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 227 Saudi Arabia nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 1 Company mapping for Large molecule bioanalytical technologies analysis, by technology
Table 2 Company mapping for Large molecule bioanalytical technologies analysis, by molecule type
Table 3 List of key technology supplier
Table 4 Some commercially available portable and handheld instruments
Table 5 Pandemic-related changes or trends in long term
Table 6 Testing types and methods
Table 7 Overview of analytical methods used in viral vector manufacturing
Table 8 North America large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 9 North America large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 10 North America large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 11 North America spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 12 North America large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 13 North America biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 14 North America biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 15 North America viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 16 North America cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 17 North America gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 18 North America nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 19 U.S. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 20 U.S. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 21 U.S. large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 22 U.S. spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 23 U.S. large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 24 U.S. biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 25 U.S. biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 26 U.S. viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 27 U.S. cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 28 U.S. gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 29 U.S. nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 30 Canada large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 31 Canada large molecule bioanalytical technologies product & service market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 32 Canada large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 33 Canada spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 34 Canada large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 35 Canada biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 36 Canada biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 37 Canada viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 38 Canada cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 39 Canada gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 40 Canada nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 41 Europe. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 42 Europe. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 43 Europe large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 44 Europe spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 45 Europe large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 46 Europe biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 47 Europe biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 48 Europe viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 49 Europe cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 50 Europe gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 51 Europe nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 52 Germany. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 53 Germany. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 54 Germany large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 55 Germany spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 56 Germany large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 57 Germany biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 58 Germany biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 59 Germany viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 60 Germany cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 61 Germany gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 62 Germany nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 63 U.K. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 64 U.K. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 65 U.K. large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 66 U.K. spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 67 U.K. large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 68 U.K. biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 69 U.K. biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 70 U.K. viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 71 U.K. cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 72 U.K. gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 73 U.K. nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 74 France. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 75 France large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 76 France large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 77 France spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 78 France large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 79 France biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 80 France biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 81 France viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 82 France cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 83 France gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 84 France nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 85 Italy large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 86 Italy large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 87 Italy large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 88 Italy spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 89 Italy large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 90 Italy biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 91 Italy biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 92 Italy viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 93 Italy cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 94 Italy gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 95 Italy nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 96 Spain. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 97 Spain. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 98 Spain large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 99 Spain spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 100 Spain large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 101 Spain biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 102 Spain biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 103 Spain viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 104 Spain cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 105 Spain gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 106 Spain nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 107 Asia Pacific. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 108 Asia Pacific. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 109 Asia Pacific large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 110 Asia Pacific spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 111 Asia Pacific large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 112 Asia Pacific biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 113 Asia Pcific biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 114 Asia Pacific viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 115 Asia Pacific cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 116 Asia Pacific gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 117 Asia Pacific nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 118 Japan large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 119 Japan large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 120 Japan large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 121 Japan spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 122 Japan large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 123 Japan biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 124 Japan biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 125 Japan viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 126 Japan cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 127 Japan gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 128 Japan nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 129 China large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 130 China large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 131 China large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 132 China spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 133 China large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 134 China biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 135 China biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 136 China viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 137 China cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 138 China gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 139 China nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 140 India large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 141 India large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 142 India large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 143 India spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 144 India large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 145 India biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 146 India biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 147 India viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 148 India cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 149 India gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 150 India nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 151 South Korea large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 152 South Korea large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 153 South Korea large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 154 South Korea spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 155 South Korea large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 156 South Korea biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 157 South Korea biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 158 South Korea viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 159 South Korea cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 160 South Korea gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 161 South Korea nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 162 Latin America large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 163 Latin America. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 164 Latin America large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 165 Latin America spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 166 Latin America large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 167 Latin America biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 168 Latin America biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 169 Latin America viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 170 Latin America cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 171 Latin America gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 172 Latin America nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 173 Brazil large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 174 Brazil. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 175 Brazil large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 176 Brazil spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 177 Brazil large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 178 Brazil biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 179 Brazil biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 180 Brazil viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 181 Brazil cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 182 Brazil gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 183 Brazil nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 184 Mexico large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 185 Mexico. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 186 Mexico large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 187 Mexico spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 188 Mexico large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 189 Mexico biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 190 Mexico biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 191 Mexico viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 192 Mexico cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 193 Mexico gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 194 Mexico nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 195 MEA large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 196 MEA large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 197 MEA large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 198 MEA spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 199 MEA large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 200 MEA biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 201 MEA biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 202 MEA viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 203 MEA cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 204 MEA gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 205 MEA nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 206 South Africa large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 207 South Africa large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 208 South Africa large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 209 South Africa spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 210 South Africa large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 211 South Africa biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 212 South Africa biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 213 South Africa viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 214 South Africa cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 215 South Africa gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 216 South Africa nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 217 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
Table 218 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
Table 219 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 220 Saudi Arabia spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 221 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 222 Saudi Arabia biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 223 Saudi Arabia biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 224 Saudi Arabia viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 225 Saudi Arabia cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 226 Saudi Arabia gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
Table 227 Saudi Arabia nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
LIST OF FIGURES
Fig. 1 Large molecule bioanalytical technologies market, 2020 (USD Million)
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research
Fig. 5 Primary research validation
Fig. 6 Market research approaches
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model assessment
Fig. 9 Industry pyramid analysis
Fig. 10 Market landscape
Fig. 11 KOL opinions: Downside Scenario
Fig. 12 KOL opinions: Future market landscape
Fig. 13 KOL opinions: Technological development
Fig. 14 Comparing protein stability analysis platforms
Fig. 15 Analytical method analysis
Fig. 16 Impact analysis of new developments by key market participants
Fig. 17 Summary of spectrometry techniques
Fig. 18 Number of biopharmaceutical products approved by the U.S.FDA (1982 - 2018)
Fig. 19 Large molecule bioanalytical technologies market segmentation
Fig. 20 Market driver relevance analysis (Current & future impact)
Fig. 21 Overview of manufacturing processes and technology innovation
Fig. 22 Market threat relevance analysis (Current & future impact)
Fig. 23 Number of recombinant and non-recombinant biopharmaceuticals approved by FDA, 2016 - 2019
Fig. 24 CDER BLA approvals of biologics & biosimilars
Fig. 25 Penetration & growth prospect mapping for therapeutic applications, 2020
Fig. 26 Large molecule bioanalytical technologies market Porter’s five forces analysis
Fig. 27 Large molecule bioanalytical technologies market: Product & service outlook key takeaways
Fig. 28 Large molecule bioanalytical technologies market: Product & service movement analysis
Fig. 29 Product market, 2017 - 2028 (USD Million)
Fig. 30 Consumables & accessories market, 2017 - 2028 (USD Million)
Fig. 31 Instruments market, 2017 - 2028 (USD Million)
Fig. 32 Reagents & kits market, 2017 - 2028 (USD Million)
Fig. 33 Service market, 2017 - 2028 (USD Million)
Fig. 34 Large molecule bioanalytical technologies market: Technology outlook key takeaways
Fig. 35 Overview of analytical tools used in viral vector manufacturing
Fig. 36 Large molecule bioanalytical technologies market: Technology movement analysis
Fig. 37 Electrophoresis techniques used in quality control of biologics
Fig. 38 Electrophoresis market, 2017 - 2028 (USD Million)
Fig. 39 Chromatography market, 2017 - 2028 (USD Million)
Fig. 40 Mass spectrometry market, 2017 - 2028 (USD Million)
Fig. 41 Key applications of quantitative western blotting for manufacture of biopharma
Fig. 42 Western blot market, 2017 - 2028 (USD Million)
Fig. 43 ddPCR, qPCR, RT-PCR market, 2017 - 2028 (USD Million)
Fig. 44 Technologies used for QC testing & characterization of AAV gene therapy vector
Fig. 45 ELISA market, 2017 - 2028 (USD Million)
Fig. 46 Flow cytometry market, 2017 - 2028 (USD Million)
Fig. 47 Spectroscopy market, 2017 - 2028 (USD Million)
Fig. 48 UV/VIS spectroscopy market, 2017 - 2028 (USD Million)
Fig. 49 CD spectroscopy market, 2017 - 2028 (USD Million)
Fig. 50 Integration of Raman spectroscopy during biopharma production
Fig. 51 Raman spectroscopy market, 2017 - 2028 (USD Million)
Fig. 52 Laser-induced breakdown spectroscopy market, 2017 - 2028 (USD Million)
Fig. 53 Other spectroscopy techniques market, 2017 - 2028 (USD Million)
Fig. 54 Key application areas of analytical ultracentrifugation
Fig. 55 Analytical ultracentrifugation market, 2017 - 2028 (USD Million)
Fig. 56 Light scattering (MALS, DLS) & static light scattering market, 2017 - 2028 (USD Million)
Fig. 57 DNA sequencing market, 2017 - 2028 (USD Million)
Fig. 58 Other technologies market, 2017 - 2028 (USD Million)
Fig. 59 Large molecule bioanalytical technologies market: Therapeutic Application outlook and key takeaways
Fig. 60 Large molecule bioanalytical technologies market: Therapeutic application movement analysis
Fig. 61 Typical analytical methods used for development and release testing of biologic therapeutics
Fig. 62 Large molecule bioanalytical technologies market estimates and forecast for biologics, 2017 - 2028 (USD Million)
Fig. 63 Global MABs market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 64 Global recombinant proteins market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 65 Global vaccines market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 66 Global spectrometer-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 67 Global western blot-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 68 Global isoelectric focusing-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 69 Global capillary electrophoresis-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 70 Global peptide mapping and sequencing by LC-MS/MS-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 71 Global peptide fingerprinting by Chromatography and Mass Spectrometry (MS)-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 72 Global ddPCR,qPCR,RT-PCR-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 73 Global other technology-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 74 Large molecule bioanalytical technologies market estimates and forecast for cell therapy, 2017 - 2028 (USD Million)
Fig. 75 Global SDS-PAGE or capillary gel electrophoresis-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 76 Global chromatography-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 77 Global mass spectrometry/LC-MS-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 78 Global UV-Vis Spectrometry assay -based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 79 Global ddPCR,qPCR,RT-PCR-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 80 Global ELISA assay -based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 81 Global fluroscent assay-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 82 Global luminescent assay-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 83 Global western-blot-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 84 Global flow cytometry-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 85 Global other technology-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 86 Large molecule bioanalytical technologies analysis estimates and forecast for viral vector 2017 - 2028 (USD Million)
Fig. 87 Global sanger-based viral vector market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 88 Global d
Fig. 1 Large molecule bioanalytical technologies market, 2020 (USD Million)
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research
Fig. 5 Primary research validation
Fig. 6 Market research approaches
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model assessment
Fig. 9 Industry pyramid analysis
Fig. 10 Market landscape
Fig. 11 KOL opinions: Downside Scenario
Fig. 12 KOL opinions: Future market landscape
Fig. 13 KOL opinions: Technological development
Fig. 14 Comparing protein stability analysis platforms
Fig. 15 Analytical method analysis
Fig. 16 Impact analysis of new developments by key market participants
Fig. 17 Summary of spectrometry techniques
Fig. 18 Number of biopharmaceutical products approved by the U.S.FDA (1982 - 2018)
Fig. 19 Large molecule bioanalytical technologies market segmentation
Fig. 20 Market driver relevance analysis (Current & future impact)
Fig. 21 Overview of manufacturing processes and technology innovation
Fig. 22 Market threat relevance analysis (Current & future impact)
Fig. 23 Number of recombinant and non-recombinant biopharmaceuticals approved by FDA, 2016 - 2019
Fig. 24 CDER BLA approvals of biologics & biosimilars
Fig. 25 Penetration & growth prospect mapping for therapeutic applications, 2020
Fig. 26 Large molecule bioanalytical technologies market Porter’s five forces analysis
Fig. 27 Large molecule bioanalytical technologies market: Product & service outlook key takeaways
Fig. 28 Large molecule bioanalytical technologies market: Product & service movement analysis
Fig. 29 Product market, 2017 - 2028 (USD Million)
Fig. 30 Consumables & accessories market, 2017 - 2028 (USD Million)
Fig. 31 Instruments market, 2017 - 2028 (USD Million)
Fig. 32 Reagents & kits market, 2017 - 2028 (USD Million)
Fig. 33 Service market, 2017 - 2028 (USD Million)
Fig. 34 Large molecule bioanalytical technologies market: Technology outlook key takeaways
Fig. 35 Overview of analytical tools used in viral vector manufacturing
Fig. 36 Large molecule bioanalytical technologies market: Technology movement analysis
Fig. 37 Electrophoresis techniques used in quality control of biologics
Fig. 38 Electrophoresis market, 2017 - 2028 (USD Million)
Fig. 39 Chromatography market, 2017 - 2028 (USD Million)
Fig. 40 Mass spectrometry market, 2017 - 2028 (USD Million)
Fig. 41 Key applications of quantitative western blotting for manufacture of biopharma
Fig. 42 Western blot market, 2017 - 2028 (USD Million)
Fig. 43 ddPCR, qPCR, RT-PCR market, 2017 - 2028 (USD Million)
Fig. 44 Technologies used for QC testing & characterization of AAV gene therapy vector
Fig. 45 ELISA market, 2017 - 2028 (USD Million)
Fig. 46 Flow cytometry market, 2017 - 2028 (USD Million)
Fig. 47 Spectroscopy market, 2017 - 2028 (USD Million)
Fig. 48 UV/VIS spectroscopy market, 2017 - 2028 (USD Million)
Fig. 49 CD spectroscopy market, 2017 - 2028 (USD Million)
Fig. 50 Integration of Raman spectroscopy during biopharma production
Fig. 51 Raman spectroscopy market, 2017 - 2028 (USD Million)
Fig. 52 Laser-induced breakdown spectroscopy market, 2017 - 2028 (USD Million)
Fig. 53 Other spectroscopy techniques market, 2017 - 2028 (USD Million)
Fig. 54 Key application areas of analytical ultracentrifugation
Fig. 55 Analytical ultracentrifugation market, 2017 - 2028 (USD Million)
Fig. 56 Light scattering (MALS, DLS) & static light scattering market, 2017 - 2028 (USD Million)
Fig. 57 DNA sequencing market, 2017 - 2028 (USD Million)
Fig. 58 Other technologies market, 2017 - 2028 (USD Million)
Fig. 59 Large molecule bioanalytical technologies market: Therapeutic Application outlook and key takeaways
Fig. 60 Large molecule bioanalytical technologies market: Therapeutic application movement analysis
Fig. 61 Typical analytical methods used for development and release testing of biologic therapeutics
Fig. 62 Large molecule bioanalytical technologies market estimates and forecast for biologics, 2017 - 2028 (USD Million)
Fig. 63 Global MABs market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 64 Global recombinant proteins market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 65 Global vaccines market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 66 Global spectrometer-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 67 Global western blot-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 68 Global isoelectric focusing-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 69 Global capillary electrophoresis-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 70 Global peptide mapping and sequencing by LC-MS/MS-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 71 Global peptide fingerprinting by Chromatography and Mass Spectrometry (MS)-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 72 Global ddPCR,qPCR,RT-PCR-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 73 Global other technology-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 74 Large molecule bioanalytical technologies market estimates and forecast for cell therapy, 2017 - 2028 (USD Million)
Fig. 75 Global SDS-PAGE or capillary gel electrophoresis-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 76 Global chromatography-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 77 Global mass spectrometry/LC-MS-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 78 Global UV-Vis Spectrometry assay -based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 79 Global ddPCR,qPCR,RT-PCR-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 80 Global ELISA assay -based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 81 Global fluroscent assay-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 82 Global luminescent assay-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 83 Global western-blot-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 84 Global flow cytometry-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 85 Global other technology-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 86 Large molecule bioanalytical technologies analysis estimates and forecast for viral vector 2017 - 2028 (USD Million)
Fig. 87 Global sanger-based viral vector market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 88 Global d
